Impact of vitamin D serum levels on clinicopathological features and outcome in advanced pancreatic carcinoma

[1] Siegel RL, Miller KD, Jemal A. CA Cancer J Clin. 2018; 68:7–30. SiegelRL MillerKD JemalA CA Cancer J Clin 2018 68 7 30 10.3322/caac.2144229313949 Search in Google Scholar

[2] Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Cancer Res. 2014; 74: 2913–2921. RahibL SmithBD AizenbergR RosenzweigAB FleshmanJM MatrisianLM Cancer Res 2014 74 2913 2921 10.1158/0008-5472.CAN-14-015524840647 Search in Google Scholar

[3] American Cancer Society. Cancer facts & figures 2017. American Cancer Society Cancer facts & figures 2017 Search in Google Scholar

[4] Van der Rhee H, Coebergh JW, de Vries E. Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies. Eur J Cancer. 2013; 49:1422–1436. Van der RheeH CoeberghJW de VriesE Is prevention of cancer by sun exposure more than just the effect of vitamin D? A systematic review of epidemiological studies Eur J Cancer 2013 49 1422 1436 10.1016/j.ejca.2012.11.00123237739 Search in Google Scholar

[5] Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, et al. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 2011; 29:1599–1606. NgK SargentDJ GoldbergRM MeyerhardtJA GreenEM PitotHC Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741 J Clin Oncol 2011 29 1599 1606 10.1200/JCO.2010.31.7255308297821422438 Search in Google Scholar

[6] Holick MF. Vitamin D deficiency. N Engl J Med, 2007; 357, 266–281. HolickMF Vitamin D deficiency N Engl J Med 2007 357 266 281 10.1056/NEJMra07055317634462 Search in Google Scholar

[7] Jacobs ET, Kohler LN, Kunihiro AG, Jurutka PW. Vitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidence. J Cancer, 2016; 7, 232–240. JacobsET KohlerLN KunihiroAG JurutkaPW Vitamin D and colorectal, breast, and prostate cancers: A review of the epidemiological evidence J Cancer 2016 7 232 240 10.7150/jca.13403474787626918035 Search in Google Scholar

[8] Waterhouse M, Risch HA, Bosetti C, Anderson KE, Petersen GM, Bamlet WR, et al. Vitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortium. Ann Oncol 2015; 26:1776–83.10.1093. WaterhouseM RischHA BosettiC AndersonKE PetersenGM BamletWR Vitamin D and pancreatic cancer: a pooled analysis from the pancreatic cancer case-control consortium Ann Oncol 2015 26 1776 83.10.1093. 10.1093/annonc/mdv236451122125977560 Search in Google Scholar

[9] Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013; 5:3993–4021.10.3390/nu5103993. MoukayedM GrantWB Molecular link between vitamin D and cancer prevention Nutrients 2013 5 3993 4021 10.3390/nu5103993 382005624084056 Open DOISearch in Google Scholar

[10] Jorde R, Grimnes G. Vitamin D and health: the need for more randomized controlled trials. J Steroid Biochem Mol Biol. 2015; 148:269–74.10.1016. JordeR GrimnesG Vitamin D and health: the need for more randomized controlled trials J Steroid Biochem Mol Biol 2015 148 269 74 10.1016. 10.1016/j.jsbmb.2015.01.02125636723 Search in Google Scholar

[11] Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D (3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012; 97:614–22.10.1210. AvenellA MacLennanGS JenkinsonDJ McPhersonGC McDonaldAM PantPR Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D (3) and/or calcium (RECORD trial) J Clin Endocrinol Metab 2012 97 614 22 10.1210 10.1210/jc.2011-130922112804 Search in Google Scholar

[12] Grant WB. A Review of the Evidence Supporting the Vitamin D Cancer Prevention Hypothesis in 2017. Anticancer Res. 2018; 38:1121–1136. GrantWB A Review of the Evidence Supporting the Vitamin D Cancer Prevention Hypothesis in 2017 Anticancer Res 2018 38 1121 1136 10.21873/anticanres.12331 Search in Google Scholar

[13] Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency, and bone health. J Clin Endocrinol Metab. 2010; 95:2630–2633. GallagherJC SaiAJ Vitamin D insufficiency, deficiency, and bone health J Clin Endocrinol Metab 2010 95 2630 2633 10.1210/jc.2010-0918290206220525913 Search in Google Scholar

[14] Cannon TL, Ford J, Hester D, Trump DL. The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer. Case Reports in Pancreatic Cancer Volume 2.1, 2016. CannonTL FordJ HesterD TrumpDL The Incidental Use of High-Dose Vitamin D3 in Pancreatic Cancer Case Reports in Pancreatic Cancer 2 1 2016 10.1089/crpc.2016.0003631968430631812 Search in Google Scholar

[15] Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O’Reilly EM, Fuchs C, Innocenti F, Venook AP; Alliance for Clinical Trials in Oncology. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014: 6;106. Van LoonK OwzarK JiangC KindlerHL MulcahyMF NiedzwieckiD O’ReillyEM FuchsC InnocentiF VenookAP Alliance for Clinical Trials in Oncology. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance) J Natl Cancer Inst 2014 6 106 10.1093/jnci/dju185415543125099612 Search in Google Scholar

[16] Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men J Natl Cancer Inst. 2006;5;98:451–459. GiovannucciE LiuY RimmEB HollisBW FuchsCS StampferMJ Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men J Natl Cancer Inst 2006 5 98 451 459 10.1093/jnci/djj10116595781 Search in Google Scholar

[17] Cho M, Peddi PF, Ding K, Chen L, Thomas D, Wang J, et al. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. J Transl Med. 2013; 11:206. ChoM PeddiPF DingK ChenL ThomasD WangJ Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma J Transl Med. 2013 11 206 10.1186/1479-5876-11-206384442324011168 Search in Google Scholar

[18] Haas M, Kern C, Kruger S, Michl M, Modest DP, Giessen C, et al. Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3. Tumour Biol. 2015; 36:2631–2640. HaasM KernC KrugerS MichlM ModestDP GiessenC Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3 Tumour Biol 2015 36 2631 2640 10.1007/s13277-014-2885-x25472579 Search in Google Scholar

[19] McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB. Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer. Nutr J. 2016; 15:17. McGovernEM LewisME NiesleyML HuynhN HoagJB Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer Nutr J. 2016 15 17 10.1186/s12937-016-0135-3475174626867933 Search in Google Scholar

[20] Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, et al. 25-Hydroxy vitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014; 106. Van LoonK OwzarK JiangC KindlerHL MulcahyMF NiedzwieckiD 25-Hydroxy vitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance) J Natl Cancer Inst. 2014 106 10.1093/jnci/dju185 Search in Google Scholar

[21] Yuan C, Qian ZR, Babic A, Morales-Oyarvide V, Rubinson DA, Kraft P, et al. Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival. J Clin Oncol. 2016; 34:2899–2905. YuanC QianZR BabicA Morales-OyarvideV RubinsonDA KraftP Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival J Clin Oncol 2016 34 2899 2905 10.1200/JCO.2015.66.3005501266227325858 Search in Google Scholar

[22] Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012; 23:363–370. TretliS SchwartzGG TorjesenPA RobsahmTE Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study Cancer Causes Control 2012 23 363 370 10.1007/s10552-011-9885-6326140022193397 Search in Google Scholar

[23] Zhang X, Huang XZ, Chen WJ, Wu J, Chen Y, Wu CC, et al. Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget. 2017: 29; 8:64395–64406 ZhangX HuangXZ ChenWJ WuJ ChenY WuCC Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysi Oncotarget 2017 29 8 64395 64406 10.18632/oncotarget.18888561001128969079 Search in Google Scholar

[24] Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, et al. Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One. 2017; 12: e0170791. GakschM JordeR GrimnesG JoakimsenR SchirmerH WilsgaardT Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium PLoS One. 2017 12 e0170791 10.1371/journal.pone.0170791531292628207791 Search in Google Scholar

[25] Duffy MJ, Murray A, Synnott NC, O’Donovan N, Crown J. Vitamin D analogues: Potential use in cancer treatment. Crit Rev Oncol Hematol. 2017; 112:190–197 DuffyMJ MurrayA SynnottNC O’DonovanN CrownJ Vitamin D analogues: Potential use in cancer treatment Crit Rev Oncol Hematol. 2017 112 190 197 10.1016/j.critrevonc.2017.02.01528325259 Search in Google Scholar

[26] Van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, et al. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations. Int J Cancer. 2018; 15; 142:1189–1201. Van DuijnhovenFJB JenabM HveemK SiersemaPD FedirkoV DuellEJ Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations Int J Cancer. 2018 15 142 1189 1201 10.1002/ijc.31146581321929114875 Search in Google Scholar

[27] Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15:1688–1695. SkinnerHG MichaudDS GiovannucciE WillettWC ColditzGA FuchsCS Vitamin D intake and the risk for pancreatic cancer in two cohort studies Cancer Epidemiol Biomarkers Prev 2006 15 1688 1695 10.1158/1055-9965.EPI-06-020616985031 Search in Google Scholar

[28] Stolzenberg-Solomon RZ, Vieth R, Azad A, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006; 66:10213–10219. Stolzenberg-SolomonRZ ViethR AzadA A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers Cancer Res 2006 66 10213 10219 10.1158/0008-5472.CAN-06-187617047087 Search in Google Scholar

[29] Stolzenberg-Solomon RZ, Hayes RB, Horst RL, et al. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009; 69:1439–1447. Stolzenberg-SolomonRZ HayesRB HorstRL Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial Cancer Res 2009 69 1439 1447 10.1158/0008-5472.CAN-08-2694305220019208842 Search in Google Scholar